Investment Analysts’ Recent Ratings Updates for Colgate-Palmolive (CL)

Colgate-Palmolive (NYSE: CL) has recently received a number of price target changes and ratings updates:

• 4/23/2026 – Colgate-Palmolive had its price target lowered by Morgan Stanley from $100.00 to $95.00. They now have an “overweight” rating on the stock.
• 4/21/2026 – Colgate-Palmolive was given a new $100.00 price target by Rothschild & Co Redburn. They now have a “buy” rating on the stock.
• 4/21/2026 – Colgate-Palmolive was upgraded by Rothschild & Co Redburn from “hold” to “buy”. They now have a $100.00 price target on the stock, up from $93.00.
• 4/17/2026 – Colgate-Palmolive had its price target lowered by JPMorgan Chase & Co. from $97.00 to $95.00. They now have an “overweight” rating on the stock.
• 4/14/2026 – Colgate-Palmolive had its price target lowered by Barclays PLC from $88.00 to $79.00. They now have an “equal weight” rating on the stock.
• 4/10/2026 – Colgate-Palmolive had its price target lowered by Bank of America Corporation from $105.00 to $102.00. They now have a “buy” rating on the stock.
• 4/9/2026 – Colgate-Palmolive was given a new $102.00 price target by Royal Bank Of Canada.
• 4/8/2026 – Colgate-Palmolive had its price target lowered by Wells Fargo & Company from $100.00 to $92.00. They now have an “equal weight” rating on the stock.
• 4/8/2026 – Colgate-Palmolive had its price target lowered by Piper Sandler from $96.00 to $92.00. They now have an “overweight” rating on the stock.
• 4/7/2026 – Colgate-Palmolive had its price target lowered by UBS Group AG from $100.00 to $98.00. They now have a “buy” rating on the stock.
• 3/31/2026 – Colgate-Palmolive had its “hold” rating reaffirmed by TD Cowen. They now have a $85.00 price target on the stock.
• 3/30/2026 – Colgate-Palmolive was upgraded by Deutsche Bank Aktiengesellschaft from “hold” to “buy”. They now have a $98.00 price target on the stock, up from $90.00.
• 3/29/2026 – Colgate-Palmolive was downgraded by Wall Street Zen from “buy” to “hold”.
• 3/21/2026 – Colgate-Palmolive was upgraded by Wall Street Zen from “hold” to “buy”.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a $0.53 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 80.92%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Sally Massey sold 15,851 shares of the stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 184,683 shares of company stock worth $17,486,693. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.